Skip to main content
logo
UroGen Pharma Ltd. (URGN)
NASDAQ: URGN · Real-Time Price · USD
43.62
-1.88 (-4.13%)
At close: Aug 28, 2026, 4:00 PM EDT
44.98
+1.36 (3.12%)
After-hours: Aug 28, 2026, 7:59 PM EDT

UroGen Pharma Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-97.64-153.49-126.87-102.24-109.78-110.82
Depreciation & Amortization
2.642.411.191.711.821.77
Other Amortization
----1.75-
Asset Writedown & Restructuring Costs
-3.13----
Loss (Gain) From Sale of Investments
-0.49-1.88-2.89-1.03-0.50.48
Stock-Based Compensation
16.1211.9613.119.3410.5823.11
Other Operating Activities
5.673.3413.7712.5213.7513.67
Change in Accounts Receivable
-69.11-12.78-4.86-2.74-0.99-4.67
Change in Inventory
-17.46-7.24-3.55-1.35-0.36-2.87
Change in Accounts Payable
8.980.2910.894.160.282
Change in Income Taxes
0.110.110.60.180.180.13
Change in Other Net Operating Assets
-7.75-8.31.863.09-4.29-7.69
Operating Cash Flow
-158.92-162.44-96.77-76.38-87.56-84.89
Operating Cash Flow Growth
------

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-0.22-0.29-0.3-0.19-0.25-0.75
Investment in Securities
40.3261.85-20.32-0.761.314.82
Investing Cash Flow
40.161.56-20.61-0.951.064.07

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Long-Term Debt Issued
--24.49-95.78-
Long-Term Debt Repaid
--1.86----
Net Debt Issued (Repaid)
62.78-1.8624.49-95.78-
Issuance of Common Stock
42.5141.77151.4968.231.5172.46
Other Financing Activities
-0-18.6448.7-0.16-0.14
Financing Cash Flow
105.2939.92194.62116.9397.1372.32

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Cash Flow
-13.53-60.9777.2439.610.64-8.5

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-159.14-162.73-97.06-76.57-87.81-85.64
Free Cash Flow Growth
------
Free Cash Flow Margin
-84.32%-148.22%-107.37%-92.57%-136.45%-178.27%
Free Cash Flow Per Share
-3.22-3.38-2.26-2.66-3.85-3.83
Levered Free Cash Flow
-106.98-99.42-46.83-35.16-42.79-44.14
Unlevered Free Cash Flow
-96.84-89.83-39.01-25.96-39.27-44.14

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Change in Working Capital
-85.22-27.914.933.34-5.18-13.11
SEC Filings: 10-K · 10-Q